Recombinant Human Insulin-like growth factor 1 receptor (IGF1R) - CD BioSciences

service-banner

Recombinant Human Insulin-like growth factor 1 receptor (IGF1R)

Recombinant Human Insulin-like growth factor 1 receptor (IGF1R)

SPP-02510

Size Price
20 μg Online Inquiry
100 μg Online Inquiry
Target Information
Species Homo sapiens
Target Name IGF Receptor
UniProt No. P08069
Subcellular Location Cell membrane, Single-pass type I membrane protein
Tissue Specificity Found as a hybrid receptor with INSR in muscle, heart, kidney, adipose tissue, skeletal muscle, hepatoma, fibroblasts, spleen and placenta (at protein level). Expressed in a variety of tissues. Overexpressed in tumors, including melanomas.
Gene Abbr. IGF1R
Full Name insulin like growth factor 1 receptor
Alias CD221, IGFIR, IGFR, JTK13
Introduction Type I insulin-like growth factor receptor (IGF-IR) is a transmembrane receptor tyrosine kinase that is widely expressed in many cell types in fetal and postnatal tissues, and which is highly similar in sequence and structure to the insulin receptor. IGF-IR is synthesized as a preproprotein which is proteolytically cleaved into alpha and beta subunits. Receptor assembly involves heterodimerization of two alpha and two beta subunits to generate the heterotetrameric transmembrane receptor. The alpha subunits form the extracellular ligand binding domain; ligand binding by IGF-I or IGF-II initiates autophosphorylation of conserved intracellular residues in the beta subunit kinase domain, leading to kinase activation and subsequent activation of downstream signal transduction pathways (e.g., Akt and MAPK). Enhanced mitogenic signaling through the IGF1R is frequently observed in cancer, making the IGF-IR an important research target in translational oncology.
Product Details
Product Type Recombinant Protein
Storage & Handling
Storage Temp. Store at -20 °C upon receipt unless otherwise instructed.
Handling Aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.